Product Name | Tafamidis |
Description |
Transthyretin Dissociation Inhibitor |
Purity | >98% (TLC); NMR (Conforms) |
CAS No. | 594839-88-0 |
Molecular Formula | C14H7Cl2NO3 |
Molecular Weight | 308.1 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | May be dissolved in DMSO (25 mg/ml, warm) |
Source | Synthetic |
Appearance | Off-white powder |
SMILES | C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl |
InChI | InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19) |
InChIKey | TXEIIPDJKFWEEC-UHFFFAOYSA-N |
Safety Phrases |
Classification: Danger- Irritant and Health Hazards GHS Hazard Statements: H315: Causes skin irritation H319: Causes serious eye irritation H335: May cause respiratory irritation H360: May damage fertility or the unborn child Precautionary Statements: P201, P202, P261, P264, P271, P280, P281, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Cite This Product | Tafamidis (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-584) |
Alternative Names | 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid, FX-1006, 2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid |
Research Areas | Alzheimer's Disease, Axon Markers, Cell Markers, Cell Signaling, Cytoskeleton, Microtubules, MT Associated Proteins, Neurodegeneration, Neuron Markers, Neuroscience, Tangles & Tau |
PubChem ID | 11001318 |
Scientific Background | Tafamidis functions as a chaperone that stabilizes the correctly folded tetrameric form of the transthyretin (TTR) protein by binding in one of the two thyroxine-binding sites of the tetramer (1). In drug form, it is used to delay impairment of peripheral nerve function in adults with familial amyloid polyneuropathy. |
References | 1. Said G, Grippon S, Kirkpatrick P. (2012). Nature Reviews. Drug Discovery. 11(3): 185–186. |
Reviews
There are no reviews yet.